Nothing Special   »   [go: up one dir, main page]

Burton et al., 2008 - Google Patents

On the pathogenicity of autoantigen-specific T-cell receptors

Burton et al., 2008

View PDF
Document ID
4653922555260173947
Author
Burton A
Vincent E
Arnold P
Lennon G
Smeltzer M
Li C
Haskins K
Hutton J
Tisch R
Sercarz E
Santamaria P
Workman C
Vignali D
Publication year
Publication venue
Diabetes

External Links

Snippet

OBJECTIVE—Type 1 diabetes is mediated by T-cell entry into pancreatic islets and destruction of insulin-producing β-cells. The relative contribution of T-cells specific for different autoantigens is largely unknown because relatively few have been assessed in …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Burton et al. On the pathogenicity of autoantigen-specific T-cell receptors
Michels et al. Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes
Lesage et al. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes
Herold et al. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Zerrahn et al. The MHC reactivity of the T cell repertoire prior to positive and negative selection
Mohan et al. Pathogenic CD4+ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes
Chen et al. Where CD4+ CD25+ T reg cells impinge on autoimmune diabetes
Wekerle Lessons from multiple sclerosis: models, concepts, observations
Unanue Antigen presentation in the autoimmune diabetes of the NOD mouse
Gioia et al. Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset
Maile et al. Peripheral “CD8 tuning” dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo
Wong et al. Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes
Baker et al. Cutting edge: nonobese diabetic mice deficient in chromogranin A are protected from autoimmune diabetes
Yang et al. Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models
Henry et al. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes
Nakayama et al. Germline TRAV5D-4 T-cell receptor sequence targets a primary insulin peptide of NOD mice
Balasa et al. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes
Yi et al. Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies
Du et al. TGF-β signaling is required for the function of insulin-reactive T regulatory cells
Jarchum et al. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A* 0201 transgenic NOD mice
Thelin et al. In vivo enrichment of diabetogenic T cells
Matsumoto et al. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice
Lee et al. Ectopic expression of self-antigen drives regulatory T cell development and not deletion of autoimmune T cells
Babad et al. T‐cell autoantigens in the non‐obese diabetic mouse model of autoimmune diabetes
Nayak et al. ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions